動物用血漿製品・誘導体市場：動物タイプ、誘導体タイプ、エンドユーザー、用途別-2025-2030年世界予測

動物用血漿製品・誘導体市場は、2024年に15億2,000万米ドルと評価され、2025年には16億3,000万米ドル、CAGR 7.71％で成長し、2030年には23億7,000万米ドルに達すると予測されています。

動物用血漿製品およびその誘導体は、研究および産業用途の両方において重要な焦点として着実に浮上してきました。長年にわたり、市場は様々な分野における高品質の生物学的材料へのニーズの拡大に牽引され、大きな成長を遂げてきました。この詳細なレポートは、業界を幅広く捉え、伝統的な手法から、現代の課題に対応する革新的な科学主導のソリューションへの進化を解明しています。

この業界は今、科学の進歩と市場の需要の岐路に立っています。バイオテクノロジーへの投資の増大と先進的な研究努力に後押しされ、抽出・精製プロセスにおける画期的な進歩により、動物血漿誘導体の有効性が最適化されました。こうした改良は品質と信頼性の向上にもつながり、製品はさまざまな用途で不可欠なものとなっています。需要が拡大するにつれ、新たな安全性、規制、技術的ベンチマークが進化し続けています。

この包括的な分析では、主要な市場促進要因を掘り下げ、変革的なシフトと細分化された洞察に関する議論の土台を築いた。また、地域別の成長のニュアンス、業界主要企業の戦略、意思決定者のための実用的な洞察についても検証しています。既存製品を改良する一方、新規の誘導体を探索する研究の役割が強調され、ダイナミックで先進的な市場が浮き彫りにされています。品質、コスト、規制要件のバランスを取る必要性がますます高まる中、本概要は、市場の有望な将来性を詳細に探るための舞台となります。

業界情勢に影響を与える変革期

近年、動物用血漿製剤とその派生品市場には、いくつかの変革的な変化が見られます。加工技術の革新と高度な分析ツールの組み合わせにより、生産効率と製品の品質が再構築されました。精製方法の向上により、誘導体製品の一貫性が高まり、厳しい規制基準と消費者の期待の高まりの両方を満たすことができるようになりました。

市場はまた、生産ラインの自動化、品質管理のための人工知能の統合、プロセス最適化のためのデータ駆動型アプローチなど、注目すべき技術的進歩の影響を受けています。こうした変化により、製造コストが削減されただけでなく、生産の拡張性も向上し、メーカーは世界の需要の急増に対応できるようになりました。同時に、規制状況の進化により、企業は透明性とコンプライアンスの強化を余儀なくされ、市場運営と長期戦略に直接的な影響を与えています。

同時に、業界各社は従来の動物血漿誘導体の枠を超えた新たな用途を開拓するため、研究開発への投資を増やしています。製品イノベーションをさらに加速させる学際的なコラボレーションやパートナーシップの動向は明らかです。新興市場でも既存市場でも需要が増加する中、メーカーは生物医学研究から消費者向け製品まで、より幅広い用途に対応するために製品ポートフォリオを再定義しています。このような戦略的転換は、技術革新と規制の進化が業界の持続的成長への道を切り開く、流動的な市場を浮き彫りにしています。

進化する市場における主要セグメンテーションの洞察

詳細なセグメンテーション分析により、動物用血漿製品およびその誘導体の市場力学を明らかにします。この業界は、動物の種類、誘導体の種類、エンドユーザー、用途に基づいてセグメント化されています。動物タイプでは、鳥、牛、羊、豚由来の製品が重視されています。これらの各カテゴリーは、様々な用途における特定の製品ニーズに応える明確な特徴をもたらします。

さらに、誘導体タイプのセグメンテーションには、ウシ胎児血清、フィブリノゲン、免疫グロブリン、血清アルブミン、トロンビンなどの必須製品が含まれます。これらの成分は、広範な生物医学的用途の基本であり、研究と治療の両方に貢献しています。エンドユーザーは食品メーカー、製薬会社、動物病院と多岐にわたる。この多様性は、業界特有の課題に対応する血漿製品の多用途性と幅広い応用可能性を示しています。

市場セグメンテーションの用途別区分は、動物飼料、生物医学研究、細胞培養培地、食品加工などの分野で製品が活躍していることから、市場の進化的性質をさらに強調しています。その他の用途としては、栄養補助食品、ペットフード産業用製剤、医薬品、化粧品、組織工学などがあります。この市場セグメンテーションの洞察は、市場が高度に専門化されていることを示唆しており、各セグメンテーションは、製品開拓と戦略的市場ポジショニングの両方を推進する、明確な消費者要件と技術革新を反映しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人間の動物肉とタンパク質の需要の増加
    • 持続可能で人道的な動物飼育慣行に関する消費者の意識が世界的に高まっている
    • 獣医医療分野における動物血漿の利用拡大
  • 抑制要因
    • 動物血漿製品の安全性と品質基準に関する厳格な規制
  • 機会
    • 革新的な製品開発のための化粧品およびスキンケアにおける血漿誘導体の新たな利用
    • 動物血漿製品の品質向上に向けたバイオテクノロジーと加工技術の継続的な革新
  • 課題
    • 動物血漿製品の合成代替品の入手可能性
• 市場セグメンテーション分析
  • 動物の種類：豚血漿製品は、高い効率とアミノ酸含有量により人気が高まっています。
  • 応用：ペットフード業界における動物血漿製品の重要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 動物用血漿製品・誘導体市場動物の種類別

• 鳥類
• 牛
• 羊
• 豚

第7章 動物用血漿製品・誘導体市場派生商品タイプ別

• 牛胎児血清
• フィブリノーゲン
• 免疫グロブリン
• 血清アルブミン
• トロンビン

第8章 動物用血漿製品・誘導体市場：エンドユーザー別

• 食品メーカー
• 製薬会社
• 獣医

第9章 動物用血漿製品・誘導体市場：用途別

• 動物飼料
• 生物医学調査
• 細胞培養培地
• 食品加工
• 栄養補助食品
• ペットフード業界
• 医薬品・化粧品
• 組織工学

第10章 南北アメリカの動物用血漿製品・誘導体市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の動物用血漿製品・誘導体市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用血漿製品・誘導体市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ACROBiosystems Inc.
• Alfa Laval Corporate AB
• ANZCO Foods Limited
• Auckland BioSciences Ltd.
• BioChemed Services
• Biowest Company
• Bovogen Biologicals Pty Ltd.
• Canvax Reagents S.L.
• Ebrator Biochemicals Inc.
• Kraeber & Co. GmbH
• Lake Immunogenics, Inc.
• LAMPIRE Biological Laboratories, Inc.
• Meiji Holdings Co., Ltd.
• Merck KGaA
• Pel-Freez, LLC
• Rockland Immunochemicals, Inc.
• Rocky Mountain Biologicals
• Scripps Laboratories, Inc.
• Sigma-Aldrich
• TCS Biosciences Ltd.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET MULTI-CURRENCY
• FIGURE 2. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET MULTI-LANGUAGE
• FIGURE 3. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET RESEARCH PROCESS
• FIGURE 4. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 200. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024

The Animal Blood Plasma Products & Derivatives Market was valued at USD 1.52 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 7.71%, reaching USD 2.37 billion by 2030.

Animal blood plasma products and derivatives have steadily emerged as a critical focus in both research and industrial applications. Over the years, the market has experienced significant growth driven by the expanding need for high-quality biological materials in various sectors. This in-depth report provides an expansive view of the industry, elucidating the evolution from traditional methodologies to innovative, science-driven solutions that meet modern-day challenges.

The industry now stands at the crossroads of scientific advancement and market demand. Fueled by increased investment in biotechnology and progressive research efforts, significant breakthroughs in extraction and purification processes have optimized the efficacy of animal plasma derivatives. These improvements have also translated into enhanced quality and reliability, making the products indispensable across multiple applications. As the demand grows, new safety, regulatory, and technological benchmarks continue to evolve.

This comprehensive analysis delves into key market drivers, laying the groundwork for a discussion on transformative shifts and segmented insights. The report also examines the nuances of regional growth, the strategies of industry-leading companies, and actionable insights for decision-makers. The role of research in refining existing products while also exploring novel derivatives is underscored, highlighting a market that is both dynamic and forward-thinking. With an ever-increasing need to balance quality, cost, and regulatory requirements, the overview sets the stage for a detailed exploration of the market's promising future.

Transformative Shifts Impacting the Industry Landscape

Recent years have witnessed several transformative shifts in the animal blood plasma products and derivatives market. Innovations in processing techniques combined with advanced analytical tools have reshaped production efficiency and product quality. Enhanced purification methods now allow for greater consistency in derived products, meeting both stringent regulatory criteria and evolving consumer expectations.

The market has also been influenced by notable technological advances, including automation in production lines, integration of artificial intelligence for quality control, and data-driven approaches to process optimization. These changes have not only reduced manufacturing costs but have also improved the scalability of production, enabling manufacturers to meet surging global demand. Simultaneously, evolving regulatory landscapes have compelled companies to enhance transparency and compliance, directly impacting market operations and long-term strategies.

Simultaneously, industry players are increasingly investing in R&D to explore new applications that extend the traditional boundaries of animal plasma derivatives. There is a clear trend toward interdisciplinary collaborations and partnerships which further accelerate product innovation. With increasing demand in both emerging and established markets, manufacturers are redefining product portfolios to address a broader array of applications ranging from biomedical research to consumer products. These strategic shifts underscore a market in flux, where technological innovation and regulatory evolution are paving the way for sustained industry growth.

Key Segmentation Insights in the Evolving Market

A detailed segmentation analysis provides a clear window into the market dynamics of animal blood plasma products and derivatives. The industry is segmented based on animal type, derivative type, end-user, and application. In terms of animal type, significant emphasis is placed on products derived from avian, bovine, ovine, and porcine sources. Each of these categories brings distinct characteristics that cater to specific product needs in various applications.

Furthermore, the derivative type segmentation encompasses essential products such as fetal bovine serum, fibrinogen, immunoglobulin, serum albumin, and thrombin. These components are fundamental in a wide range of biomedical applications, contributing to both research and therapeutic practices. The end-user segmentation spans food manufacturers, pharmaceutical companies, and veterinary services. This diversity demonstrates the versatility and broad applicability of plasma products in addressing industry-specific challenges.

Application-based segmentation further underscores the market's evolving nature, with products making their mark in areas like animal feed, biomedical research, cell culture media, and food processing. Additional applications include nutrition supplements, pet food industry formulations, pharmaceuticals and cosmetics, as well as tissue engineering. This segmentation insight suggests that the market is highly specialized, with each segment reflecting distinct consumer requirements and technological innovations which drive both product development and strategic market positioning.

Based on Animal Type, market is studied across Avian, Bovine, Ovine, and Porcine.

Based on Derivative Type, market is studied across Fetal Bovine Serum, Fibrinogen, Immunoglobulin, Serum Albumin, and Thrombin.

Based on End-User, market is studied across Food Manufacturers, Pharmaceutical Companies, and Veterinary.

Based on Application, market is studied across Animal Feed, Biomedical Research, Cell Culture Media, Food Processing, Nutrition Supplements, Pet Food Industry, Pharmaceuticals & Cosmetics, and Tissue Engineering.

Essential Regional Insights Shaping Market Trends

The animal blood plasma products and derivatives market exhibits noteworthy regional variations that reflect broader economic, regulatory, and technological influences. In the Americas, robust growth is underpinned by advanced research facilities, a strong biotechnology sector, and an aggressive approach to regulatory compliance. These factors ensure sustained demand among established industry players as well as emerging enterprises. Meanwhile, this region benefits from extensive partnerships that drive innovation and set the pace for quality enhancements in product formulations.

Across the region encompassing Europe, the Middle East, and Africa, the market is evolving at a measured pace. Technological advancements and rigorous quality standards have positioned these areas as key contributors to in-depth scientific research and product development. Companies in this region are strategically investing in state-of-the-art infrastructure and R&D, which has resulted in notable improvements in process efficiency and product consistency. The emphasis on research collaboration and regional regulatory alignment has further facilitated market penetration and international trade.

In the Asia-Pacific region, rapid industrialization coupled with a growing demand for high-quality biologics has established an impressive growth trajectory. Technological integration and increasing investment in biotechnology have catalyzed local market innovation, positioning the region as a critical hub for both production and research. The interplay of these regional insights demonstrates that while each geographic area presents unique challenges, collectively they contribute to a resilient and forward-moving market landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Growth

The landscape of animal blood plasma products and derivatives is bolstered by the significant contributions of several key market players who not only drive innovation but also contribute to market stability and growth. Leading companies such as ACROBiosystems Inc. and Alfa Laval Corporate AB contribute through cutting-edge research and by setting high production standards in the field. Organizations including ANZCO Foods Limited and Auckland BioSciences Ltd. have expanded the market reach by integrating advanced production facilities with global distribution channels.

Other prominent players, including BioChemed Services, Biowest Company, and Bovogen Biologicals Pty Ltd., further enhance the product quality spectrum by focusing on state-of-the-art derivatization practices. Companies like Canvax Reagents S.L. and Ebrator Biochemicals Inc. emphasize innovation and technological frontiers to ensure that products not only meet but exceed industry standards. Moreover, the contributions of Kraeber & Co. GmbH, Lake Immunogenics, Inc., and LAMPIRE Biological Laboratories, Inc. span global markets by combining research excellence with operational efficiency.

In addition, industry leaders such as Meiji Holdings Co., Ltd., Merck KGaA, and Pel-Freez, LLC have cemented their positions through significant R&D investments that drive competitive advantages. The market also benefits from the strategic insights provided by organizations like Rockland Immunochemicals, Inc., Rocky Mountain Biologicals, Scripps Laboratories, Inc., and Sigma-Aldrich. Collaborations and technological synergies with TCS Biosciences Ltd. and Thermo Fisher Scientific Inc. have led to innovative product lines and enhanced service offerings, thereby reinforcing the market's future prospects.

The report delves into recent significant developments in the Animal Blood Plasma Products & Derivatives Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Alfa Laval Corporate AB, ANZCO Foods Limited, Auckland BioSciences Ltd., BioChemed Services, Biowest Company, Bovogen Biologicals Pty Ltd., Canvax Reagents S.L., Ebrator Biochemicals Inc., Kraeber & Co. GmbH, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., Meiji Holdings Co., Ltd., Merck KGaA, Pel-Freez, LLC, Rockland Immunochemicals, Inc., Rocky Mountain Biologicals, Scripps Laboratories, Inc., Sigma-Aldrich, TCS Biosciences Ltd., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

Industry decision-makers are positioned to accelerate growth by focusing on advancements in R&D and by streamlining operational efficiencies. Leaders should prioritize investment in next-generation processing technologies that elevate product purity and yield. It is essential to foster strategic partnerships that bridge research institutions with production facilities to harness cutting-edge developments and meet the changing market demands. By actively monitoring regulatory updates and aligning with global standards, companies can mitigate compliance risks while maintaining a competitive edge.

Furthermore, optimizing the supply chain and enhancing quality control measures will support timely market entry and reduce production bottlenecks. Establishing robust data analytics frameworks provides actionable intelligence that informs decision-making processes and tailors product development to the precise needs of diverse market segments. Ultimately, a focused approach that couples technological innovation with operational excellence will enable industry leaders to sustain growth and capitalize on emerging opportunities.

Conclusion and Future Market Prospects

The analysis of animal blood plasma products and derivatives reveals an industry rich in opportunity and resilient against market fluctuations. Driven by technological advancements, insightful segmentation, and an evolving regulatory environment, the market continues to demonstrate robust growth. The integration of innovative production techniques and diversification across various applications has created an ecosystem where research and development lead to tangible, market-ready outcomes.

As the industry moves forward, it is clear that embracing both regional nuances and the strategic insights of key companies will be instrumental in shaping future directions. The balance between quality enhancements and regulatory compliance continues to be a defining factor in enabling market leaders to achieve sustained success. With continued innovation and strategic collaborations, the prospects for the market remain highly promising, offering growth potential that is both extensive and diverse.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for animal meat and protein among human population
    • 5.1.1.2. Rising consumer awareness concerning sustainable and humane animal farming practices globally
    • 5.1.1.3. Expanding utilization of animal blood plasma in veterinary care applications
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulations for safety and quality standards for animal blood plasma products
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging use of blood plasma derivatives in cosmetics and skincare for innovative product development
    • 5.1.3.2. Ongoing innovations in biotechnology and processing techniques to improve the quality of animal blood plasma products
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of synthetic alternatives to animal blood plasma products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Animal Type: Rising preference for porcine plasma products owing to high efficiency and amino acid
  • 5.2.2. Application: Increasing significance of animal blood plasma products in pet food industry
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Blood Plasma Products & Derivatives Market, by Animal Type

• 6.1. Introduction
• 6.2. Avian
• 6.3. Bovine
• 6.4. Ovine
• 6.5. Porcine

7. Animal Blood Plasma Products & Derivatives Market, by Derivative Type

• 7.1. Introduction
• 7.2. Fetal Bovine Serum
• 7.3. Fibrinogen
• 7.4. Immunoglobulin
• 7.5. Serum Albumin
• 7.6. Thrombin

8. Animal Blood Plasma Products & Derivatives Market, by End-User

• 8.1. Introduction
• 8.2. Food Manufacturers
• 8.3. Pharmaceutical Companies
• 8.4. Veterinary

9. Animal Blood Plasma Products & Derivatives Market, by Application

• 9.1. Introduction
• 9.2. Animal Feed
• 9.3. Biomedical Research
• 9.4. Cell Culture Media
• 9.5. Food Processing
• 9.6. Nutrition Supplements
• 9.7. Pet Food Industry
• 9.8. Pharmaceuticals & Cosmetics
• 9.9. Tissue Engineering

10. Americas Animal Blood Plasma Products & Derivatives Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Animal Blood Plasma Products & Derivatives Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Animal Blood Plasma Products & Derivatives Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Gemini Bioproducts expands its portfolio by acquiring Bio-Techne's key fetal bovine serum brands
  • 13.3.2. FDA clearance of PrecisePRP Canine transform veterinary care with innovative platelet-rich plasma solution
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACROBiosystems Inc.
• 2. Alfa Laval Corporate AB
• 3. ANZCO Foods Limited
• 4. Auckland BioSciences Ltd.
• 5. BioChemed Services
• 6. Biowest Company
• 7. Bovogen Biologicals Pty Ltd.
• 8. Canvax Reagents S.L.
• 9. Ebrator Biochemicals Inc.
• 10. Kraeber & Co. GmbH
• 11. Lake Immunogenics, Inc.
• 12. LAMPIRE Biological Laboratories, Inc.
• 13. Meiji Holdings Co., Ltd.
• 14. Merck KGaA
• 15. Pel-Freez, LLC
• 16. Rockland Immunochemicals, Inc.
• 17. Rocky Mountain Biologicals
• 18. Scripps Laboratories, Inc.
• 19. Sigma-Aldrich
• 20. TCS Biosciences Ltd.
• 21. Thermo Fisher Scientific Inc.